mechanism of glp 1 receptor agonists Frontiers Frontiers | GLP−1 receptor agonists

Drugs used commonly in IIH have been shown to worsen cognitive impairments in patients, with acetazolamide and topiramate worsening fluid intelligence [12]

[DOI] [PubMed] [Google Scholar] 28.Cho Y.M., Fujita Y., Kieffer T.J

Shares of the Danish drugmaker fell 16% on the news that Novos CagriSema delivered 20.2% weight loss in 84 weeks, compared with 23.6% for Lillys tirzepatide, aka Zepbound

Lets look at the remission data for sleep apnea and some other chronic conditions after various bariatric interventions: LSG (Sleeve Gastrectomy) resulted in a 75.8% remission rate for sleep apnea

Notably in ten of the cases the patients had enlarged duodenal mucosa

Therefore, more clinical trials utilizing a large generalizable T2DM patient population with less influence from baseline characteristics and longer follow-up durations are needed to help guide clinical decision-making and reduce the burden of T2DM while also promoting cardiovascular health